FIRST MANHATTAN CO. LLC. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 61 filers reported holding CASI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$61,000
-33.7%
30,0000.0%0.00%
Q4 2019$92,000
-8.0%
30,0000.0%0.00%
-100.0%
Q3 2019$100,000
+4.2%
30,0000.0%0.00%0.0%
Q2 2019$96,000
+11.6%
30,0000.0%0.00%
Q1 2019$86,000
-28.3%
30,0000.0%0.00%
-100.0%
Q4 2018$120,000
-14.3%
30,0000.0%0.00%0.0%
Q3 2018$140,000
-43.1%
30,0000.0%0.00%0.0%
Q2 2018$246,00030,0000.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 896,137$4,185,0002.27%
Wellington Shields Capital Management, LLC 888,333$4,149,0000.67%
Manatuck Hill Partners, LLC 15,090$70,0000.03%
IHT Wealth Management, LLC 10,725$50,0000.01%
Perceptive Advisors 43,682$204,0000.01%
ALPS ADVISORS INC 153,234$716,0000.01%
ROYCE & ASSOCIATES LP 78,742$368,0000.00%
MEEDER ASSET MANAGEMENT INC 5,863$28,0000.00%
Tower Research Capital LLC (TRC) 5,974$28,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 18,585$86,7920.00%
View complete list of CASI PHARMACEUTICALS INC shareholders